KardiologiiaHumansFemaleCardiovascular DiseasesMenopauseMetabolic Diseases
[Russian Eligibility Criteria for Prescribing Menopausal Hormone Therapy to Patients With Cardiovascular and Metabolic Diseases. Consensus Document of RSC, RSOG, RAE, EUAT, RAP, RSMSI, RAGG].
E V Shlyakhto, I I Dedov, V N Serov, G T Sukhikh, G P Arutyunov, I A Suchkov, O M Drapkina, O N Tkacheva, Ia A Orlova, I I Baranov, E N Andreeva, S V Yureneva, M I Yarmolinskaya, A A Smetnik, S V Villevalde
Published: 202510.18087/cardio.2025.11.n3056
Abstract
Menopausal symptoms can disrupt women's well-being at the peak of their careers and family life. Currently, the most effective treatment for these symptoms is menopausal hormone therapy (MHT). The presence of cardiovascular and metabolic diseases doe…
Preview only. Read the full abstract at the source